High potency cannabis is associated with tripled risk of psychosis, study indicates
BMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h939 (Published 18 February 2015) Cite this as: BMJ 2015;350:h939- Ingrid Torjesen
- 1London
Users of high potency (“skunk-like”) cannabis are three times as likely to have a psychotic episode as people who never use cannabis, and the risk is fivefold in people who smoke this form of the drug every day, a study published in Lancet Psychiatry this week concludes.1
Between 1 May 2005 and 31 May 2011 researchers from the Institute of Psychiatry, Psychology and Neuroscience at King’s College London studied 410 patients who had experienced a first episode of psychosis and collected data on their cannabis use. These data were compared with data collected from 370 people from the …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.